Sigachi Industries Limited

SIGACHI

INE0D0K01022

Pharmaceuticals

Market Closed - NSE India S.E. Other stock markets 12:40:22 18/05/2024 pm IST			5-day change	1st Jan Change
69.2 ^INR	+4.93%		+6.87%	+34.63%

06/04	Sigachi Industries Limited Announces Resignation of Shreya Mitra as Company Secretary & Compliance Officer	CI
27/02	Sigachi MENA FZCO Unit, iConsult Establish Joint Venture for UAE Business	MT

Sigachi Industries Limited Announces Opening of New Corporate Office

August 30, 2023 at 02:34 pm IST

Sigachi Industries Limited announced that the Company has set up a Corporate Office at Plot No.G 57/2, Survey no.70 & 174, Sultanpur Village, Patancheru Mandal, Hyderabad, Sanga Reddy District, Telangana- 502319 and the operations from the said Corporate office commence from September 4, 2023.

Latest news about Sigachi Industries Limited

Sigachi Industries Limited Announces Resignation of Shreya Mitra as Company Secretary & Compliance Officer	06/04	CI
Sigachi MENA FZCO Unit, iConsult Establish Joint Venture for UAE Business	27/02	MT
Sigachi MENA FZCO, A Wholly Owned Subsidiary of the Sigachi Industries Limited and iConsult Trading Consultancy LLC Announce Formation of Joint Venture, Sigachi Global	26/02	CI
Sigachi Industries Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	19/01	CI
Sigachi Industries Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	14/11	CI
Sigachi Industries Limited announced that it has received INR 716.11875 million in funding from a group of investors	14/11	CI
Sigachi Industries' Dubai-based Arm to Form Saudi Arabian JV	20/23/20	MT
Sigachi Industries Limited Declares Dividend for the Financial Year 2022-23	07/23/07	CI
Sigachi Industries Sets Up New Corporate Office in Hyderabad, India	31/23/31	MT
Sigachi Industries Limited Announces Opening of New Corporate Office	30/23/30	CI
Sigachi Industries Limited Recommends Dividend for the Financial Year 2022-23	16/23/16	CI
Sigachi Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	10/23/10	CI
Sigachi Industries Limited agreed to acquire 80% stake in Trimax Bio Sciences Private Limited for INR 1 billion.	10/23/10	CI
Sigachi Industries' Consolidated Profit Plummets in Fiscal Q4	25/23/25	MT
Sigachi Industries Limited Recommends Dividend	25/23/25	CI
Sigachi Industries Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	25/23/25	CI
Sigachi Looks to Acquire API Units for Forward Integration	06/23/06	CI
Sigachi Industries Limited Announces Resignation of Mohankrishna Reddy Arvabumi as Director	16/23/16	CI
Sigachi Industries Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	30/23/30	CI
Sigachi Industries Limited Approves Board Changes	10/23/10	CI
CARE Retains A- Rating on Sigachi Industries' Long-term Bank Financing; Outlook Stable	05/23/05	MT
Certain Equity Shares of Sigachi Industries Limited are subject to a Lock-Up Agreement Ending on 10-NOV-2022.	10/22/10	CI
Sigachi Industries Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	27/22/27	CI
Sigachi Industries Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	22/22/22	CI
Sigachi Industries Limited Announces Launch of Health Care Division	22/22/22	CI

Chart Sigachi Industries Limited

Duration

Period

More charts

Company Profile

Sigachi Industries Limited is an India-based company that manufactures primarily microcrystalline cellulose (MCC). The Company is engaged in manufacturing cellulose-based excipients for finished dosages in the pharmaceutical industry. The Companyâs products include EXCiPACT GMP, SGMP, HACCP and EDQM CEP. The Company's pre-formulated excipients include BARETab PH, BARETab ODT and BARETab Nutra. It produces MCC in various grades ranging from 15 to 250 microns for the domestic and export markets under the HiCel and AceCel brands. The Company offers Anti-ulcers (Gastrointestinal) Products and their Intermediates. It operates over three manufacturing units situated in Hyderabad, Jhagadia and Dahej. The Company serves pharmaceutical, food and nutraceuticals, cosmetic and chemical industries. Its international business spreads across 50 countries, including Asia, Australia, American Continent, Europe and the Middle East.

Sector

Pharmaceuticals

Calendar

19/07/2024 - Q1 2025 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Other Pharmaceuticals

	1st Jan change	Capi.
SIGACHI INDUSTRIES LIMITED	+34.63%	269M
ELI LILLY AND COMPANY	+34.32%	693B
NOVO NORDISK A/S	+29.39%	584B
JOHNSON & JOHNSON	-2.90%	372B
MERCK & CO., INC.	+20.56%	332B
ABBVIE INC.	+6.58%	294B
ASTRAZENECA PLC	+14.11%	239B
ROCHE HOLDING AG	-3.03%	211B
NOVARTIS AG	+10.02%	210B
AMGEN INC.	+8.93%	168B

Other Pharmaceuticals